Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
[The poliomyelitis epidemic in northern Tr|ondelag 1950].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

LANGE HF, PAULSEN PE, VOGT JH.
PMID: 13005464
Tidsskr Nor Laegeforen. 1952 Aug 01;72(15):471-5; passim.

No abstract available.

Cite
LANGE HF, PAULSEN PE, VOGT JH. Erfaringer fra poliomyelitt-epidemien i Nord-Tr|ondelag i 1950. [The poliomyelitis epidemic in northern Tr|ondelag 1950]. Tidsskr Nor Laegeforen. 1952;72(15):471-5; passim
LANGE, H. F., PAULSEN, P. E., & VOGT, J. H. (1952). Erfaringer fra poliomyelitt-epidemien i Nord-Tr|ondelag i 1950. [The poliomyelitis epidemic in northern Tr|ondelag 1950]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 72(15), 471-5; passim.
LANGE, H F, et al. "Erfaringer fra poliomyelitt-epidemien i Nord-Tr|ondelag i 1950." [The poliomyelitis epidemic in northern Tr|ondelag 1950]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 72,15 (1952): 471-5; passim.
LANGE HF, PAULSEN PE, VOGT JH. Erfaringer fra poliomyelitt-epidemien i Nord-Tr|ondelag i 1950. [The poliomyelitis epidemic in northern Tr|ondelag 1950]. Tidsskr Nor Laegeforen. 1952 Aug 01;72(15):471-5; passim. Undetermined. PMID: 13005464.
Copy Download .nbib Format: NLM
Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage.

Advances in radiation oncology

Dunn EF, Akhtar A, Dunn A, Lacey S, Pauley E, Powers C, McKee J, Petereit D.
PMID: 33283072
Adv Radiat Oncol. 2021 Mar-Apr;6(2):100636. doi: 10.1016/j.adro.2020.100636. Epub 2020 Dec 01.

PURPOSE: The supply of N95 masks and filtering facepiece respirators (FFRs) has been limited nationally owing to the coronavirus disease 2019 pandemic. Ultraviolet C (UVC) light has been suggested as a potential option for decontamination of FFRs by the...

Cite
Dunn EF, Akhtar A, Dunn A, et al. Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage. Adv Radiat Oncol. 2020;6(2):100636doi: 10.1016/j.adro.2020.100636.
Dunn, E. F., Akhtar, A., Dunn, A., Lacey, S., Pauley, E., Powers, C., McKee, J., & Petereit, D. (2021). Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage. Advances in radiation oncology, 6(2), 100636. https://doi.org/10.1016/j.adro.2020.100636
Dunn, Emily F, et al. "Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage." Advances in radiation oncology vol. 6,2 (2021): 100636. doi: https://doi.org/10.1016/j.adro.2020.100636
Dunn EF, Akhtar A, Dunn A, Lacey S, Pauley E, Powers C, McKee J, Petereit D. Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage. Adv Radiat Oncol. 2021 Mar-Apr;6(2):100636. doi: 10.1016/j.adro.2020.100636. Epub 2020 Dec 01. PMID: 33283072; PMCID: PMC7705333.
Copy Download .nbib Format: NLM
Do over 200 million healthy altitude residents really suffer from chronic Acid-base disorders?.

Indian journal of clinical biochemistry : IJCB

Zubieta-Calleja G, Zubieta-Castillo G, Zubieta-Calleja L, Ardaya-Zubieta G, Paulev PE.
PMID: 22211016
Indian J Clin Biochem. 2011 Jan;26(1):62-5. doi: 10.1007/s12291-010-0088-9. Epub 2010 Nov 16.

As the oxygen tension of inspired air falls with increasing altitude in normal subjects, hyperventilation ensues. This acute respiratory alkalosis, induces increased renal excretion of bicarbonate, returning the pH back to normal, giving rise to compensated respiratory alkalosis or...

Cite
Zubieta-Calleja G, Zubieta-Castillo G, Zubieta-Calleja L, et al. Do over 200 million healthy altitude residents really suffer from chronic Acid-base disorders?. Indian J Clin Biochem. 2010;26(1):62-5doi: 10.1007/s12291-010-0088-9.
Zubieta-Calleja, G., Zubieta-Castillo, G., Zubieta-Calleja, L., Ardaya-Zubieta, G., & Paulev, P. E. (2011). Do over 200 million healthy altitude residents really suffer from chronic Acid-base disorders?. Indian journal of clinical biochemistry : IJCB, 26(1), 62-5. https://doi.org/10.1007/s12291-010-0088-9
Zubieta-Calleja, Gustavo, et al. "Do over 200 million healthy altitude residents really suffer from chronic Acid-base disorders?." Indian journal of clinical biochemistry : IJCB vol. 26,1 (2011): 62-5. doi: https://doi.org/10.1007/s12291-010-0088-9
Zubieta-Calleja G, Zubieta-Castillo G, Zubieta-Calleja L, Ardaya-Zubieta G, Paulev PE. Do over 200 million healthy altitude residents really suffer from chronic Acid-base disorders?. Indian J Clin Biochem. 2011 Jan;26(1):62-5. doi: 10.1007/s12291-010-0088-9. Epub 2010 Nov 16. PMID: 22211016; PMCID: PMC3068777.
Copy Download .nbib Format: NLM
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol.

The Lancet regional health. Europe

Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, Gillesen A, Berry C, Lowe DJ, McPeake J, Lone N, Munblit D, Cevik M, Casey A, Bannister P, Russell CD, Goodwin L, Ho A, Turtle L, O'Hara ME, Hastie C, Donohue C, Spencer RG, Donegan C, Gummery A, Harrison J, Hardwick HE, Hastie CE, Carson G, Merson L, Baillie JK, Openshaw P, Harrison EM, Docherty AB, Semple MG, Scott JT.
PMID: 34386785
Lancet Reg Health Eur. 2021 Sep;8:100186. doi: 10.1016/j.lanepe.2021.100186. Epub 2021 Aug 06.

BACKGROUND: This study sought to establish the long-term effects of Covid-19 following hospitalisation.METHODS: 327 hospitalised participants, with SARS-CoV-2 infection were recruited into a prospective multicentre cohort study at least 3 months post-discharge. The primary outcome was self-reported recovery at...

Cite
Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186doi: 10.1016/j.lanepe.2021.100186.
Sigfrid, L., Drake, T. M., Pauley, E., Jesudason, E. C., Olliaro, P., Lim, W. S., Gillesen, A., Berry, C., Lowe, D. J., McPeake, J., Lone, N., Munblit, D., Cevik, M., Casey, A., Bannister, P., Russell, C. D., Goodwin, L., Ho, A., Turtle, L., O'Hara, M. E., Hastie, C., Donohue, C., Spencer, R. G., Donegan, C., Gummery, A., Harrison, J., Hardwick, H. E., Hastie, C. E., Carson, G., Merson, L., Baillie, J. K., Openshaw, P., Harrison, E. M., Docherty, A. B., Semple, M. G., Scott, J. T. (2021). Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. The Lancet regional health. Europe, 8100186. https://doi.org/10.1016/j.lanepe.2021.100186
Sigfrid, Louise, et al. "Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol." The Lancet regional health. Europe vol. 8 (2021): 100186. doi: https://doi.org/10.1016/j.lanepe.2021.100186
Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, Gillesen A, Berry C, Lowe DJ, McPeake J, Lone N, Munblit D, Cevik M, Casey A, Bannister P, Russell CD, Goodwin L, Ho A, Turtle L, O'Hara ME, Hastie C, Donohue C, Spencer RG, Donegan C, Gummery A, Harrison J, Hardwick HE, Hastie CE, Carson G, Merson L, Baillie JK, Openshaw P, Harrison EM, Docherty AB, Semple MG, Scott JT. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021 Sep;8:100186. doi: 10.1016/j.lanepe.2021.100186. Epub 2021 Aug 06. PMID: 34386785; PMCID: PMC8343377.
Copy Download .nbib Format: NLM
Recurrent renal cell carcinoma presenting as a cutaneous metastasis: A case report and review of the literature.

Urology annals

Leve PP, Felício J, Carneiro R, Zagalo C.
PMID: 34194146
Urol Ann. 2021 Apr-Jun;13(2):174-176. doi: 10.4103/UA.UA_2_20. Epub 2021 Apr 13.

Renal cell carcinoma (RCC) is a common urological malignancy. Despite early detection and surgical treatment, some lesions recur late at distant sites. The most common dissemination sites are lung, bone, and liver. Skin metastases are not common, and the...

Cite
Leve PP, Felício J, Carneiro R, et al. Recurrent renal cell carcinoma presenting as a cutaneous metastasis: A case report and review of the literature. Urol Ann. 2021;13(2):174-176doi: 10.4103/UA.UA_2_20.
Leve, P. P., Felício, J., Carneiro, R., & Zagalo, C. (2021). Recurrent renal cell carcinoma presenting as a cutaneous metastasis: A case report and review of the literature. Urology annals, 13(2), 174-176. https://doi.org/10.4103/UA.UA_2_20
Leve, Paulo Pe, et al. "Recurrent renal cell carcinoma presenting as a cutaneous metastasis: A case report and review of the literature." Urology annals vol. 13,2 (2021): 174-176. doi: https://doi.org/10.4103/UA.UA_2_20
Leve PP, Felício J, Carneiro R, Zagalo C. Recurrent renal cell carcinoma presenting as a cutaneous metastasis: A case report and review of the literature. Urol Ann. 2021 Apr-Jun;13(2):174-176. doi: 10.4103/UA.UA_2_20. Epub 2021 Apr 13. PMID: 34194146; PMCID: PMC8210725.
Copy Download .nbib Format: NLM
Letter to the Editor re: "Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A Theoretical Model and Systematic Review" by Ramirez-Sandoval et al. (High Alt Med Biol 2016;17:85-92).

High altitude medicine & biology

Zubieta-Calleja G, Zubieta-DeUrioste N, Paulev PE.
PMID: 27689471
High Alt Med Biol. 2016 Sep;17(3):240. doi: 10.1089/ham.2016.0073.

No abstract available.

Cite
Zubieta-Calleja G, Zubieta-DeUrioste N, Paulev PE. Letter to the Editor re: "Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A Theoretical Model and Systematic Review" by Ramirez-Sandoval et al. (High Alt Med Biol 2016;17:85-92). High Alt Med Biol. 2016;17(3):240doi: 10.1089/ham.2016.0073.
Zubieta-Calleja, G., Zubieta-DeUrioste, N., & Paulev, P. E. (2016). Letter to the Editor re: "Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A Theoretical Model and Systematic Review" by Ramirez-Sandoval et al. (High Alt Med Biol 2016;17:85-92). High altitude medicine & biology, 17(3), 240. https://doi.org/10.1089/ham.2016.0073
Zubieta-Calleja, Gustavo, et al. "Letter to the Editor re: "Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A Theoretical Model and Systematic Review" by Ramirez-Sandoval et al. (High Alt Med Biol 2016;17:85-92)." High altitude medicine & biology vol. 17,3 (2016): 240. doi: https://doi.org/10.1089/ham.2016.0073
Zubieta-Calleja G, Zubieta-DeUrioste N, Paulev PE. Letter to the Editor re: "Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A Theoretical Model and Systematic Review" by Ramirez-Sandoval et al. (High Alt Med Biol 2016;17:85-92). High Alt Med Biol. 2016 Sep;17(3):240. doi: 10.1089/ham.2016.0073. PMID: 27689471.
Copy Download .nbib Format: NLM
The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience.

Therapeutic advances in neurological disorders

Bauer S, Willems LM, Paule E, Petschow C, Zöllner JP, Rosenow F, Strzelczyk A.
PMID: 28382109
Ther Adv Neurol Disord. 2017 Feb;10(2):103-126. doi: 10.1177/1756285616675777. Epub 2016 Nov 29.

Lacosamide (LCM) is approved for anticonvulsive treatment in focal epilepsy and exhibits its function through the slow inactivation of voltage-gated sodium channels (VGSCs). LCM shows comparable efficacy with other antiepileptic drugs (AEDs) licensed in the last decade: in three...

Cite
Bauer S, Willems LM, Paule E, et al. The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience. Ther Adv Neurol Disord. 2016;10(2):103-126doi: 10.1177/1756285616675777.
Bauer, S., Willems, L. M., Paule, E., Petschow, C., Zöllner, J. P., Rosenow, F., & Strzelczyk, A. (2017). The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience. Therapeutic advances in neurological disorders, 10(2), 103-126. https://doi.org/10.1177/1756285616675777
Bauer, Sebastian, et al. "The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience." Therapeutic advances in neurological disorders vol. 10,2 (2017): 103-126. doi: https://doi.org/10.1177/1756285616675777
Bauer S, Willems LM, Paule E, Petschow C, Zöllner JP, Rosenow F, Strzelczyk A. The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience. Ther Adv Neurol Disord. 2017 Feb;10(2):103-126. doi: 10.1177/1756285616675777. Epub 2016 Nov 29. PMID: 28382109; PMCID: PMC5367645.
Copy Download .nbib Format: NLM
Deleterious mutations in .

NPJ genomic medicine

Sarret C, Ashkavand Z, Paules E, Dorboz I, Pediaditakis P, Sumner S, Eymard-Pierre E, Francannet C, Krupenko NI, Boespflug-Tanguy O, Krupenko SA.
PMID: 31341639
NPJ Genom Med. 2019 Jul 23;4:17. doi: 10.1038/s41525-019-0092-9. eCollection 2019.

Neuro-ichthyotic syndromes are a group of rare genetic diseases mainly associated with perturbations in lipid metabolism, intracellular vesicle trafficking, or glycoprotein synthesis. Here, we report a patient with a neuro-ichthyotic syndrome associated with deleterious mutations in the

Cite
Sarret C, Ashkavand Z, Paules E, et al. Deleterious mutations in . NPJ Genom Med. 2019;4:17doi: 10.1038/s41525-019-0092-9.
Sarret, C., Ashkavand, Z., Paules, E., Dorboz, I., Pediaditakis, P., Sumner, S., Eymard-Pierre, E., Francannet, C., Krupenko, N. I., Boespflug-Tanguy, O., & Krupenko, S. A. (2019). Deleterious mutations in . NPJ genomic medicine, 417. https://doi.org/10.1038/s41525-019-0092-9
Sarret, Catherine, et al. "Deleterious mutations in ." NPJ genomic medicine vol. 4 (2019): 17. doi: https://doi.org/10.1038/s41525-019-0092-9
Sarret C, Ashkavand Z, Paules E, Dorboz I, Pediaditakis P, Sumner S, Eymard-Pierre E, Francannet C, Krupenko NI, Boespflug-Tanguy O, Krupenko SA. Deleterious mutations in . NPJ Genom Med. 2019 Jul 23;4:17. doi: 10.1038/s41525-019-0092-9. eCollection 2019. PMID: 31341639; PMCID: PMC6650503.
Copy Download .nbib Format: NLM
Left Ventricular Thrombus Formation in the Setting of Normal Systolic Function.

JACC. Case reports

Svendsen C, Pauley E, Stouffer GA.
PMID: 34316999
JACC Case Rep. 2020 Jun 24;2(10):1470-1474. doi: 10.1016/j.jaccas.2020.05.027. eCollection 2020 Aug.

We describe the case of a 42-year-old female with recurrent left ventricular (LV) thrombus and multiple embolic events despite having normal LV systolic function. The clinical presentation, associated conditions, diagnostic evaluation and treatment of patients with LV thrombus in...

Cite
Svendsen C, Pauley E, Stouffer GA. Left Ventricular Thrombus Formation in the Setting of Normal Systolic Function. JACC Case Rep. 2020;2(10):1470-1474doi: 10.1016/j.jaccas.2020.05.027.
Svendsen, C., Pauley, E., & Stouffer, G. A. (2020). Left Ventricular Thrombus Formation in the Setting of Normal Systolic Function. JACC. Case reports, 2(10), 1470-1474. https://doi.org/10.1016/j.jaccas.2020.05.027
Svendsen, Christopher, et al. "Left Ventricular Thrombus Formation in the Setting of Normal Systolic Function." JACC. Case reports vol. 2,10 (2020): 1470-1474. doi: https://doi.org/10.1016/j.jaccas.2020.05.027
Svendsen C, Pauley E, Stouffer GA. Left Ventricular Thrombus Formation in the Setting of Normal Systolic Function. JACC Case Rep. 2020 Jun 24;2(10):1470-1474. doi: 10.1016/j.jaccas.2020.05.027. eCollection 2020 Aug. PMID: 34316999; PMCID: PMC8302091.
Copy Download .nbib Format: NLM
The Andrews-Sellers family of partition congruences.

Advances in mathematics

Paule P, Radu CS.
PMID: 23471147
Adv Math (N Y). 2012 Jun 20;230(3):819-838. doi: 10.1016/j.aim.2012.02.026.

In 1994, James Sellers conjectured an infinite family of Ramanujan type congruences for 2-colored Frobenius partitions introduced by George E. Andrews. These congruences arise modulo powers of 5. In 2002 Dennis Eichhorn and Sellers were able to settle the...

Cite
Paule P, Radu CS. The Andrews-Sellers family of partition congruences. Adv Math (N Y). 2012;230(3):819-838doi: 10.1016/j.aim.2012.02.026.
Paule, P., & Radu, C. S. (2012). The Andrews-Sellers family of partition congruences. Advances in mathematics, 230(3), 819-838. https://doi.org/10.1016/j.aim.2012.02.026
Paule, Peter, and Radu, Cristian-Silviu. "The Andrews-Sellers family of partition congruences." Advances in mathematics vol. 230,3 (2012): 819-838. doi: https://doi.org/10.1016/j.aim.2012.02.026
Paule P, Radu CS. The Andrews-Sellers family of partition congruences. Adv Math (N Y). 2012 Jun 20;230(3):819-838. doi: 10.1016/j.aim.2012.02.026. PMID: 23471147; PMCID: PMC3587391.
Copy Download .nbib Format: NLM
Barriers to Uptake of Insulin Technologies and Novel Solutions.

Medical devices (Auckland, N.Z.)

Pauley ME, Berget C, Messer LH, Forlenza GP.
PMID: 34803408
Med Devices (Auckl). 2021 Nov 12;14:339-354. doi: 10.2147/MDER.S312858. eCollection 2021.

Diabetes-related technology has undergone great advancement in recent years. These technological devices are more commonly utilized in the type 1 diabetes population, which requires insulin as the primary treatment modality. Available devices include insulin pumps, continuous glucose monitors, and...

Cite
Pauley ME, Berget C, Messer LH, et al. Barriers to Uptake of Insulin Technologies and Novel Solutions. Med Devices (Auckl). 2021;14:339-354doi: 10.2147/MDER.S312858.
Pauley, M. E., Berget, C., Messer, L. H., & Forlenza, G. P. (2021). Barriers to Uptake of Insulin Technologies and Novel Solutions. Medical devices (Auckland, N.Z.), 14339-354. https://doi.org/10.2147/MDER.S312858
Pauley, Meghan E, et al. "Barriers to Uptake of Insulin Technologies and Novel Solutions." Medical devices (Auckland, N.Z.) vol. 14 (2021): 339-354. doi: https://doi.org/10.2147/MDER.S312858
Pauley ME, Berget C, Messer LH, Forlenza GP. Barriers to Uptake of Insulin Technologies and Novel Solutions. Med Devices (Auckl). 2021 Nov 12;14:339-354. doi: 10.2147/MDER.S312858. eCollection 2021. PMID: 34803408; PMCID: PMC8594891.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries